New rapid test could speed up care for severe postpartum bleeding
NCT ID NCT06255002
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new rapid bedside device (qLabs®FIB) that measures a key blood clotting protein called fibrinogen in women with severe bleeding after childbirth. The goal was to see if the quick test gives results as accurate as the standard lab test, which takes longer. 70 women participated, and the findings could help doctors make faster treatment decisions during emergencies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Cochin Maternité Port Royal
Paris, 75014, France
-
Hôpital Necker-Enfants Malades
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple calcium tablet help prevent postpartum bleeding?
- Medical glue vs. internal bleeding: a new hope?
- Which drug stops Post-Birth bleeding better? a Head-to-Head test
- Could a simple calcium injection prevent dangerous bleeding after childbirth?
- Blood-Clotting showdown: which device best guides bleeding care in High-Risk patients?
- Simple C-Section techniques could slash postpartum bleeding risk